
The impact of drug pricing and reimbursement on the pharmaceutical industry
A recent survey for GlobalData’s “State of the Biopharmaceutical Industry 2025” report, conducted at the end of 2024, found drug pricing and reimbursement constraints represent the biggest concern for pharmaceutical industry decision makers over the coming …